Ilma Korponay-Szabo

Aktiviteetit

Aktiviteetteja vuodessa 2006 2009 2011 2012 2013 2017

• 62 Konferenssiesitelmä
• 4 Kutsuttu esitelmä
• 1 Konferenssiin, työryhmään, paneeliin, sessioon tai tutoriaaliin osallistuminen

Aktiviteetteja vuodessa

Hakutulokset

• From seropositivity to final CD diagnosis - the way with challenges and solutions

  Ilma Korponay-Szabó (Speaker)

  9 marrask. 2017

  Aktiviteetti: Konferenssiesitelmä

• The induction of early developing celiac disease in mice by injection of celiac disease patient sera or immunoglobulins

  Suvi Kalliokoski (Contributor), Katri Kaukinen (Contributor), Ilma Korponay-Szabó (Contributor), Kaija Laurila (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  1 heinäk. 2014

  Aktiviteetti: Konferenssiesitelmä

• Transglutaminase expression and coeliac antibodies in the pancreas in diabetes mellitus

  Ilma Korponay-Szabó (Speaker), Maarit Oikarinen (Speaker), Jutta Laiho (Speaker), Kaija Laurila (Speaker), Markku Mäki (Speaker) & Heikki Hyöty (Speaker)

  10 kesäk. 2014

  Aktiviteetti: Konferenssiesitelmä

• Coeliac disease and immunoglobulin IgA nephropathy : the missing link

  Katri Kaukinen (Contributor), Ilma Korponay-Szabó (Contributor), Kaija Laurila (Contributor), Katri Lindfors (Contributor), Jukka Mustonen (Contributor) & Markku Mäki (Contributor)

  10 kesäk. 2014

  Aktiviteetti: Konferenssiesitelmä

• Celiac Disease–Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell Dynamics

  Suvi Kalliokoski (Contributor), Ana-Marija Sulic (Contributor), Ilma R. Korponay-Szabó (Contributor), Zsuzsa Szondy (Contributor), Rafael Frias (Contributor), Mileidys Alea Perez (Contributor), Stefania Martucciello (Contributor), Anne Roivainen (Contributor), Lauri J. Pelliniemi (Contributor), Carla Esposito (Contributor), Martin Griffin (Contributor), Sblattero Daniele (Contributor), Markku Mäki (Contributor), Katri Kaukinen (Contributor), Katri Lindfors (Contributor) & Sergio Caja (Contributor)

  13 helmik. 2014

  Aktiviteetti: Konferenssiesitelmä

• Injection of celiac patient serum or immunoglobulins to mice reproduces a condition mimicking early developing celiac disease

  Suvi Kalliokoski (Contributor), Sergio Caja (Contributor), Ilma Korponay-Szabó (Contributor), Rafael Frias (Contributor), Outi Koskinen (Contributor), Markku Mäki (Contributor), Katri Kaukinen (Contributor) & Katri Lindfors (Contributor)

  17 jouluk. 2013

  Aktiviteetti: Konferenssiesitelmä

• Coeliac disease manifestation in early age in a prospectively followed contemporary natural history cohort of first degree relatives

  Judit Gyimesi (Contributor), Éva Nemes (Contributor), Erika Vajda-Nagy (Contributor), Orsolya Kadenczki (Contributor) & Ilma Korponay-Szabo (Contributor)

  16 lokak. 2013

  Aktiviteetti: Konferenssiesitelmä

• Evolution and HLA-association of the early infantile gliadin antibody response in a high-risk cohort for coeliac disease

  Ilma Korponay-Szabo (Contributor), Sibylle Koletzko (Contributor), Judit Gyimesi (Contributor), Gemma Castillejo (Contributor), Eckart Mummert (Contributor), Enzo Bravi (Contributor), Carmen Ribes-Koninckx (Contributor), Isabel Polanco (Contributor), Raanan Shamir (Contributor), Sanja Kolacek (Contributor), Riccardo Troncone (Contributor) & Luisa Mearin (Contributor)

  16 lokak. 2013

  Aktiviteetti: Konferenssiesitelmä

• Molecular basis for the myocardium involvement in coeliac disease

  Ilma Korponay-Szabó (Contributor) & Markku Mäki (Contributor)

  16 lokak. 2013

  Aktiviteetti: Konferenssiesitelmä

• Celiac disease patient IgA mediates endothelial adhesion and cell polarization defects via extracellular transglutaminase 2

  Cristina Nadalutti (Contributor), Ilma Korponay-Szabó (Contributor), Katri Kaukinen (Contributor), Martin Griffin (Contributor), Markku Mäki (Contributor) & Katri Lindfors (Contributor)

  25 syysk. 2013

  Aktiviteetti: Konferenssiesitelmä

• Thioredoxin is involved in endothelial cell extracellular transglutaminase 2 activation

  Cristina Nadalutti (Contributor), Ilma Korponay-Szabó (Contributor), Katri Kaukinen (Contributor), Wang Zhuo (Contributor), Martin Griffin (Contributor), Markku Mäki (Contributor) & K Lindfors (Contributor)

  25 syysk. 2013

  Aktiviteetti: Konferenssiesitelmä

• A new method for long-term culturing of intestinal biopsies derived from coeliac disease patients using mice as carriers

  Markku Mäki (Contributor), Sergio Caja Galan (Contributor), Ilma Korponay-Szabó (Contributor) & Katri Lindfors (Contributor)

  23 syysk. 2013

  Aktiviteetti: Konferenssiesitelmä

• Injection of coeliac patient immunoglobulins to mice reproduces a condition mimicking early developing coeliac disease

  Suvi Kalliokoski (Speaker), Sergio Caja Galan (Speaker), Katri Kaukinen (Speaker), Ilma Korponay-Szabó (Speaker), Katri Lindfors (Speaker) & Markku Mäki (Speaker)

  23 syysk. 2013

  Aktiviteetti: Konferenssiesitelmä

• Clinical spectrum of unselected newly diagnosed celiac disease patients – data from the observational multi-center study Procede

  Katharina Werkstetter (Contributor), Sibylle Koletzko (Contributor), Steffen Husby (Contributor), Luisa Mearin (Contributor), Ilma Korponay-Szabó (Contributor), Carmen Ribes-Konickx (Contributor), Adrian Thomas (Contributor), Riccardo Troncone (Contributor), Vincenzo Villanacci (Contributor), Enzo Bravi (Contributor), Ulf Steller (Contributor), Andreas Vécsei (Contributor), Almuthe Hauer (Contributor), Myriam Van Winckel (Contributor), Philippe Alliët (Contributor), Francoise Smets (Contributor), Zrinjka Misak (Contributor), Peter Szitányi (Contributor), Kalle Kurppa (Contributor), Hélène Garnier-Lengliné (Contributor) & Yvan Vanderplas (Contributor)

  22 syysk. 2013

  Aktiviteetti: Konferenssiesitelmä

• Injection of coeliac patient immunoglobulins to mice reproduces a condition mimicking early developing coeliac disease

  Suvi Kalliokoski (Contributor), Sergio Caja Galan (Contributor), Katri Kaukinen (Contributor), Ilma Korponay-Szabó (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  11 kesäk. 2013

  Aktiviteetti: Konferenssiesitelmä

• Antibodies in celiac disease - experiences from the PreventCD study

  Ilma Korponay-Szabó (Keynote speaker)

  27 toukok. 2013

  Aktiviteetti: Kutsuttu esitelmä

• Molecular basis for the myocardium involvement in coeliac disease

  Ilma Korponay-Szabó (Contributor) & Markku Mäki (Contributor)

  10 toukok. 2013

  Aktiviteetti: Konferenssiesitelmä

• Lipoma-preferred partner protein (LPP), a genetic marker for coeliac disease predisposition is interacting with transglutaminase 2

  B Tóth (Contributor), R Bogáti (Contributor), R Király (Contributor), Z Simon-Vecsei (Contributor), Sergio Caja Galan (Contributor), B Barta-Tóth (Contributor), C Nadalutti (Contributor), K Lindfors (Contributor), M Mäki (Contributor), L Fésüs (Contributor) & I Korponay-Szabo (Contributor)

  10 toukok. 2013

  Aktiviteetti: Konferenssiesitelmä

• Clinical spectrum of unselected newly diagnosed coeliac disease patients – data from the observational multi-center study Procede

  Katharina Werkstetter (Contributor), Sibylle Koletzko (Contributor), Steffen Husby (Contributor), Luisa Mearin (Contributor), Ilma Korponay-Szabó (Contributor), Carmen Ribes-Konickx (Contributor), Adrian Thomas (Contributor), Riccardo Troncone (Contributor), Vincenzo Villanacci (Contributor), Enzo Bravi (Contributor), Ulf Steller (Contributor), Andreas Vécsei (Contributor), Almuthe Hauer (Contributor), Myriam Van Winckel (Contributor), Philippe Alliët (Contributor), Yvan Vanderplas (Contributor), Francoise Smets (Contributor), Zrinjka Misak (Contributor), Peter Szitányi (Contributor), Kalle Kurppa (Contributor) & Hélène Garnier-Lengliné (Contributor)

  8 toukok. 2013

  Aktiviteetti: Konferenssiesitelmä

• Celiac disease–specific TG2-targeted autoantibodies inhibit angiogenesis in vivo in mice by modulating extracellular matrix

  Suvi Kalliokoski (Contributor), Sergio Caja Galan (Contributor), Katri Kaukinen (Contributor), Ilma Korponay-Szabó (Contributor), Katri Lindfors (Contributor), Markku Mäki (Contributor) & Ana-Marija Sulic (Contributor)

  14 helmik. 2013

  Aktiviteetti: Konferenssiesitelmä

• A new method for culturing intestinal biopsies derived from coeliac disease patients using a mouse model

  Markku Mäki (Contributor), Sergio Caja Galan (Contributor), Ilma Korponay-Szabó (Contributor) & Katri Lindfors (Contributor)

  14 helmik. 2013

  Aktiviteetti: Konferenssiesitelmä

• A new method for culturing intestinal biopsies derived from coeliac disease patients using a mouse model

  Emily McKinney (Contributor), Sergio Caja Galan (Contributor), Ilma Korponay-Szabó (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  18 jouluk. 2012

  Aktiviteetti: Konferenssiesitelmä

• Injection of coeliac patient serum or immunoglobulins to mice reproduces a condition mimicking early developing coeliac disease

  Suvi Kalliokoski (Contributor), Sergio Caja Galan (Contributor), Katri Kaukinen (Contributor), Ilma Korponay-Szabó (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  18 jouluk. 2012

  Aktiviteetti: Konferenssiesitelmä

• Validation of a symptom-antibody-genetics-endoscopic histology score (SAGE) for coeliac disease by traditional interlaken diagnostic process

  Ilma Korponay-Szabó (Contributor) & Markku Mäki (Contributor)

  24 lokak. 2012

  Aktiviteetti: Konferenssiesitelmä

• Point of care testing in coeliac disease, pros and cons

  Ilma Korponay-Szabo (Keynote speaker)

  8 syysk. 2012

  Aktiviteetti: Kutsuttu esitelmä

• A new method for culturing intestinal biopsies derived from coeliac disease patients using a mouse model

  Emily McKinney (Contributor), Boglarka Toth (Contributor), Markku Maki (Contributor), Katri Lindfors (Contributor), Ilma Korponay-Szabo (Contributor) & Sergio Caja (Contributor)

  8 syysk. 2012

  Aktiviteetti: Konferenssiesitelmä

• How good are antibodies in diagnosing coeliac disease

  Ilma Korponay-Szabo (Keynote speaker)

  8 syysk. 2012

  Aktiviteetti: Kutsuttu esitelmä

• Injection of coeliac patient serum or immunoglobulins to mice reproduces a condition mimicking early developing coeliac disease

  Suvi Kalliokoski (Contributor), Sergio Caja Galan (Contributor), Katri Kaukinen (Contributor), Ilma Korponay-Szabó (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  7 syysk. 2012

  Aktiviteetti: Konferenssiesitelmä

• TG2 epitopes for coeliac autoantibodies and their significance

  Ilma Korponay-Szabó (Keynote speaker)

  7 syysk. 2012

  Aktiviteetti: Kutsuttu esitelmä

• International Coeliac Disease Scientific Conference; Better Life for Coeliacs

  Ilma Korponay-Szabó (Osallistuja)

  6 syysk. 2012 → 8 syysk. 2012

  Aktiviteetti: Konferenssiin, työryhmään, paneeliin, sessioon tai tutoriaaliin osallistuminen

• Injection of celiac patient serum or immunoglobulins to mice reproduces a condition mimicking early developing celiac disease

  Suvi Kalliokoski (Contributor), Sergio Caja (Contributor), Ilma R. Korponay-Szabó (Contributor), Rafael Frias (Contributor), Outi Koskinen (Contributor), Markku Mäki (Contributor), Katri Kaukinen (Contributor) & Katri Lindfors (Contributor)

  16 heinäk. 2012

  Aktiviteetti: Konferenssiesitelmä

• Passive transfer of celiac patient serum or purified serum immunoglobulins induce features of early developing celiac disease in mice

  Katri Lindfors (Speaker), Sergio Caja Galan (Speaker), Suvi Kalliokoski (Speaker), Katri Kaukinen (Speaker), Ilma Korponay-Szabó (Speaker) & Markku Mäki (Speaker)

  11 toukok. 2012

  Aktiviteetti: Konferenssiesitelmä

• Validation of a symptom-antibody-genetics-endoscopic histology (SAGE) score for diagnosing coeliac disease in problem patients

  Ilma Korponay-Szabó (Speaker) & Markku Mäki (Speaker)

  28 huhtik. 2012

  Aktiviteetti: Konferenssiesitelmä

• Injection of coeliac patient serum or immunoglobulins to mice reproduces a condition mimicking early developing coeliac disease

  Suvi Kalliokoski (Contributor), Sergio Caja (Contributor), Ilma Korponay-Szabó (Contributor), Rafael Frias (Contributor), Outi Koskinen (Contributor), Markku Mäki (Contributor), Katri Kaukinen (Contributor) & Katri Lindfors (Contributor)

  27 huhtik. 2012

  Aktiviteetti: Konferenssiesitelmä

• New diagnostic criteria for coeliac disease : role of antibody markers?

  Ilma Korponay-Szabó (Speaker)

  24 maalisk. 2012

  Aktiviteetti: Konferenssiesitelmä

• Injection of coeliac patient serum or immunoglobulins to mice reproduces a condition mimicking early developing coeliac disease

  Suvi Kalliokoski (Speaker), Sergio Caja (Speaker), Ilma R. Korponay-Szabó (Speaker), Rafael Frias (Speaker), Outi Koskinen (Speaker), Markku Mäki (Speaker), Katri Kaukinen (Speaker) & Katri Lindfors (Speaker)

  9 helmik. 2012

  Aktiviteetti: Konferenssiesitelmä

• Injection of coeliac patient serum or immunoglobulins to mice reproduces a condition mimicking early developing coeliac disease

  Suvi Kalliokoski (Contributor), Sergio Caja Galan (Contributor), Katri Kaukinen (Contributor), Ilma Korponay-Szabó (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  15 jouluk. 2011

  Aktiviteetti: Konferenssiesitelmä

• Features of early developing coeliac diasease can be induced in mice by passive transfer of patient serum

  Suvi Kalliokoski (Contributor), Sergio Caja Galan (Contributor), Katri Kaukinen (Contributor), Ilma Korponay-Szabó (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  22 marrask. 2011

  Aktiviteetti: Konferenssiesitelmä

• Using a symptom-antibody-genetics-endoscopy (SAGE) score to predict coeliac disease in patients without villous atrophy

  Ilma Korponay-Szabó (Contributor) & Markku Mäki (Contributor)

  24 lokak. 2011

  Aktiviteetti: Konferenssiesitelmä

• Reaction with the recombinant tag as cause of false positive transglutaminase antibody results

  Ilma Korponay-Szabó (Contributor)

  23 lokak. 2011

  Aktiviteetti: Konferenssiesitelmä

• Are TG2 inhibitors able to decrease gliadin-induced toxicity related to coeliac disease?

  Tiina Rauhavirta (Contributor), Rami Kivistö (Contributor), Ilma Korponay-Szabó (Contributor), Pekka T Männistö (Contributor), J. Arturo Garcia-Horsman (Contributor), Mongeot Alexandre (Contributor), Russell Collighan (Contributor), Martin Griffin (Contributor), Markku Mäki (Contributor), Katri Kaukinen (Contributor) & Katri Lindfors (Contributor)

  22 kesäk. 2011

  Aktiviteetti: Konferenssiesitelmä

• Celiac Patient Transglutaminase 2-Targeted Autoantibodies Inhibit in Vivo Angiogenesis Likely Through Overexpression of RhoB

  Katri Lindfors (Speaker), Sergio Caja (Speaker), Stefanie Martucciello (Speaker), Miha Lavric (Speaker), Ilma Korponay-Szabo (Speaker), Cristina Nadalutti (Speaker), Tiina Rauhavirta (Speaker), Carla Esposito (Speaker), Ana-Marija Sulic (Speaker), Daniele Sblattero (Speaker), Roberto Marzari (Speaker), Markku Mäki (Speaker) & Katri Kaukinen (Speaker)

  28 toukok. 2011

  Aktiviteetti: Konferenssiesitelmä

• Celiac patient transglutaminase 2-targeted autoantibodies inhibit in vivo angiogenesis likely through overexpression of RhoB

  Katri Lindfors (Contributor), Sergio Caja (Contributor), Stefanie Martucciello (Contributor), Miha Lavric (Contributor), Ilma Korponay-Szabo (Contributor), Cristina Nadalutti (Contributor), Tiina Rauhavirta (Contributor), Carla Esposito (Contributor), Ana-Marija Sulic (Contributor), Daniele Sblattero (Contributor), Roberto Marzari (Contributor), Markku Mäki (Contributor) & Katri Kaukinen (Contributor)

  28 toukok. 2011

  Aktiviteetti: Konferenssiesitelmä

• Development and validation of a simple diagnostic score for coeliac disease (SAGE) based on symptoms, antibodies, HLA genotypes and biopsy results

  I Korponay-Szabo (Contributor), J Gyimesi (Contributor), J Tumpek (Contributor), E Nemes (Contributor), M Mäki (Contributor) & JB Kovacs (Contributor)

  26 toukok. 2011

  Aktiviteetti: Konferenssiesitelmä

• Overexpression of RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies

  Katri Lindfors (Contributor), Sergio Caja Galan (Contributor), Katri Kaukinen (Contributor), Ilma Korponay-Szabó (Contributor), Markku Mäki (Contributor), Cristina Nadalutti (Contributor) & Tiina Rauhavirta (Contributor)

  9 toukok. 2011

  Aktiviteetti: Konferenssiesitelmä

• Passive transfer of celiac disease into mice – Part II

  Suvi Kalliokoski (Contributor), Sergio Caja Galan (Contributor), Katri Kaukinen (Contributor), Ilma Korponay-Szabó (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  19 tammik. 2011

  Aktiviteetti: Konferenssiesitelmä

• Passive transfer of celiac disease into mice - Part II

  Suvi Kalliokoski (Contributor), Sergio Caja Galan (Contributor), Katri Kaukinen (Contributor), Ilma Korponay-Szabó (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  15 jouluk. 2010

  Aktiviteetti: Konferenssiesitelmä

• Identification of the disease-specific coeliac epitope of transglutaminase 2 and possible antibody-based therapy

  Katri Lindfors (Speaker), Ilma Korponay-Szabó (Speaker) & Markku Mäki (Speaker)

  10 kesäk. 2010

  Aktiviteetti: Konferenssiesitelmä

• Features of celiac disease can be induced in mice by passive transfer of patient serum

  Suvi Kalliokoski (Contributor), Sergio Caja (Contributor), Ilma R. Korponay-Szabó (Contributor), Outi Koskinen (Contributor), Markku Mäki (Contributor), Katri Kaukinen (Contributor) & Katri Lindfors (Contributor)

  20 tammik. 2010

  Aktiviteetti: Konferenssiesitelmä

• Features of celiac diasease can be induced in mice by passive transfer of patient serum

  S Kalliokoski (Speaker), S Caja (Speaker), Ilma Korponay-Szabó (Speaker), O Koskinen (Speaker), M Mäki (Speaker), K Kaukinen (Speaker) & K Lindfors (Speaker)

  18 jouluk. 2009

  Aktiviteetti: Konferenssiesitelmä